Harbour Investments Inc. Sells 252 Shares of iShares Biotechnology ETF $IBB

Harbour Investments Inc. cut its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 13.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,600 shares of the financial services provider’s stock after selling 252 shares during the quarter. Harbour Investments Inc.’s holdings in iShares Biotechnology ETF were worth $202,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Ramirez Asset Management Inc. bought a new position in iShares Biotechnology ETF during the first quarter worth $26,000. Berkshire Money Management Inc. bought a new position in iShares Biotechnology ETF during the second quarter worth $28,000. Financial Gravity Asset Management Inc. bought a new position in iShares Biotechnology ETF during the first quarter worth $30,000. Woodside Wealth Management LLC bought a new position in iShares Biotechnology ETF during the first quarter worth $31,000. Finally, Trust Co. of Toledo NA OH bought a new position in shares of iShares Biotechnology ETF in the second quarter valued at $32,000. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Down 1.4%

iShares Biotechnology ETF stock opened at $153.92 on Thursday. iShares Biotechnology ETF has a 1-year low of $107.43 and a 1-year high of $157.19. The firm’s fifty day moving average price is $144.20 and its two-hundred day moving average price is $132.09.

iShares Biotechnology ETF Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 19th. Shareholders of record on Tuesday, September 16th were paid a $0.0828 dividend. This represents a $0.33 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend was Tuesday, September 16th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.